Incentives for Product and Process Innovations: A Case for the Drug Industry
Aditya Bhan and
Additional contact information
Aditya Bhan: Economic Research Unit, Indian Statistical Institute, Kolkata, India
Tarun Kabiraj: Economic Research Unit, Indian Statistical Institute, Kolkata, India
Indian Economic Review, 2014, vol. 49, issue 2, 193-204
We consider an interaction of competing firms in an integrated world market and study their R&D incentives under each of product patent and process patent regimes. We follow a framework generally observed in the drug industry. We show that product patent regime leads to a larger R&D investment. Consumers may also benefit from product patenting. However, if the number of goods is large enough, the choice of patent regime loses significance with respect to R&D incentives.
Keywords: Innovation; Process Patenting; Product Patenting; Drug Industry (search for similar items in EconPapers)
JEL-codes: F23 L13 O34 (search for similar items in EconPapers)
References: Add references at CitEc
Citations Track citations by RSS feed
There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
Persistent link: https://EconPapers.repec.org/RePEc:dse:indecr:0090
Ordering information: This journal article can be ordered from
Access Statistics for this article
Indian Economic Review is currently edited by Pami Dua (Editor) & Ram Singh (Associate Editor) and Sunil Kanwar
More articles in Indian Economic Review from Department of Economics, Delhi School of Economics University of Delhi, Delhi 110 007. Contact information at EDIRC.
Series data maintained by Pami Dua ().